Development and Validation of a Thyroid Cancer-Specific Health-Related Quality of Life Questionnaire for Adult Filipinos with Differentiated Thyroid Cancer
Keywords:
thyroid cancer, quality of life, questionnaire, Philippines, validation studiesAbstract
Objectives. The study aims to develop and validate a health-related quality of life (HRQoL) questionnaire for adult Filipinos with differentiated thyroid cancer (DTC) that can be used in combination with the European Organization for Research and Treatment of Cancer QLQ-C30 Questionnaire.
Methodology. The study had 4 phases. Phase I involved generation of HRQoL issues from literature review, focus group discussions with 6 DTC patients and 5 health care professionals (HCP). Subsequent assessment for relevance and importance of the HRQoL issues by 20 patients and HCP panel was done. Phase II was formulation of the HRQoL issues into questionnaire and subsequent translation into Filipino. Phase III was pilot testing of the questionnaire in 15 patients. Phase IV was validation of the pre-final questionnaire in 231 patients.
Results. In Phase I, 28 HRQoL issues were generated. In Phase II, a 28-item Filipino questionnaire was created. In Phase III, 22 items that were not upsetting or confusing to patients and with good range of responses were retained. After Phase IV, a 22-item questionnaire with 5 conceptual scales (perceived fears, psychological distress/anxiety, functionality, voice complaints, neck complaints) was created.
Conclusions. The developed and validated 22-item questionnaire can be used to assess HRQoL issues in adult Filipinos with DTC.
Downloads
References
Curado MP, Edwards B, Shin HR, et al (eds). Cancer Incidence in Five Continents, vol. IX, IARC Sci Publ No. 160. Lyon, France: International Agency for Research on Cancer, 2007. Available from: http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/CI5vol9.pdf Accessed April 2015.
Redaniel MTM, Laudico AV, Lumague MRM, Mapua CA, Patama T, Pukkala E. Cancer in the Philippines, vol. IV, part 1 - Cancer Incidence 1998-2002. Manila: Philippine Cancer Society, 2008. Available from: http://www.philcancer.org.ph/wp-content/uploads/2014/ 07/Cancer-in-the-Philippines-Vol.-IV-part-1.pdf. Accessed April 2015.
Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2012, National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2012/. Accessed April 2015.
Almeida, JP, Vartanian, JG, Kowalski, LP. Clinical predictors of quality of life in patients with initial differentiated thyroid cancers. Arch Otolaryngol Head Neck Surg. 2009;135(4):342-6. https://doi.org/10.1001/archoto.2009.16.
Rubic M, Kuna SK, Tesic V, Samardzic T, Despot M, Huic D. The most common factors influencing on quality of life of thyroid cancer patients after thyroid hormone withdrawal. Psychiatr Danub. 2014;26(Suppl 3):520-7. PMID: 25536991.
Gómez MMN, Gutiérrez RMV, Castellanos SAO, Vergara MP, Pradilla YKR. Psychological well-being and quality of life in patients treated for thyroid cancer after surgery. Terapia Psicologica. 2010:28(1):69-84. https://doi.org/10.4067/S0718-48082010000100007.
Centers for Disease Control and Prevention. Measuring healthy days: Population assessment of health-related quality of life. Atlanta, Georgia: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2000. Available from: https://www.cdc.gov/hrqol/pdfs/mhd.pdf. Accessed April 2015.
Husson O, Haak HR, Oranje WA, Mols F, Reemst PHM, van de Poll- Franse LV. Health-related quality of life among thyroid cancer survivors: A systematic review. Clin Endocrinol (Oxf). 2011;75(4):544– 54. https://doi.org/10.1111/j.1365-2265.2011.04114.x.
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76. https://doi.org/ 10.1093/jnci/85.5.365.
Husson O, Haak HR, Mols F, et al. Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors. Acta Oncol. 2013;52(2):447-54. https://doi.org/ 10.3109/0284186X.2012.718445.
Johnson, C, Aaronson N, Blazeby JM, et al. EORTC Quality of Life Group Guidelines for Developing Questionnaire Modules, 4th ed, April 2011. Available from: http://groups.eortc.be/qol/sites/default/files/ archives/guidelines_for_developing_questionnaire-_final.pdf. Accessed April 2015.
Nunnally JC, Bernstein IH. Book review: Psychometric theory. 3rd ed. New York: McGraw-Hill, 1994.
Jeong Y, Choi J, Ahn A, et al. Validation of the Korean version of the thyroid cancer-specific quality of life questionnaire. Ann Surg Treat Res. 2015;89(6): 287–294. https://doi.org/10.4174/astr.2015.89.6.287.
Dow KH, Ferrell BR, Anello C. Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid. 1997;7(4):613–9. https://doi.org/10.1089/thy.1997.7.613.
Singer S, Andry G, Araújo C, et al. EORTC QOL Module for Thyroid Cancer (QLQ-THY). Available from: http://groups.eortc.be/qol/eortcqol- module-thyroid-cancer-qlq-thy. Accessed April 2015.
Published
How to Cite
Issue
Section
License
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.
